United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 262,126 | 154,030 | 263,425 | 157,013 | 156,666 |
| Marketable Securities | 408,516 | 325,175 | 240,032 | 235,355 | 252,300 |
| Receivables | 101,347 | 116,626 | 108,949 | 98,584 | 89,150 |
| Inventories | 39,743 | 37,254 | 46,848 | 46,631 | 45,760 |
| Income taxes - deferred | 14,554 | N/A | 8,199 | 8,199 | 8,199 |
| Other current assets | 5,838 | 35,385 | 37,390 | 24,825 | 21,844 |
| TOTAL | $844,567 | $668,470 | $718,185 | $570,607 | $573,919 |
| Non-Current Assets | |||||
| PPE Net | 449,076 | 453,685 | 439,894 | 435,751 | 401,587 |
| Investments And Advances | 211,508 | 311,103 | 254,232 | 314,337 | 342,330 |
| Other Non-Current Assets | 192,204 | 193,337 | 235,181 | 235,706 | 243,599 |
| TOTAL | $852,788 | $958,125 | $929,307 | $985,794 | $987,516 |
| Total Assets | $1,697,355 | $1,626,595 | $1,647,492 | $1,556,401 | $1,561,435 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,291 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 10,194 | 10,203 | 10,130 | 8,695 | 8,335 |
| Accrued Expenses | 67,338 | 72,985 | 87,635 | 67,211 | 58,590 |
| Other current liabilities | 99,072 | 92,276 | 129,850 | 111,756 | 108,617 |
| TOTAL | $176,604 | $176,755 | $227,615 | $187,662 | $175,542 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 70,343 | N/A | N/A | 71,431 |
| Other Non-Current Liabilities | 370,047 | 295,516 | 359,046 | 359,140 | 289,813 |
| TOTAL | $370,047 | $365,859 | $359,046 | $359,140 | $361,244 |
| Total Liabilities | $546,651 | $542,614 | $586,661 | $546,802 | $536,786 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,708 | 50,183 | 50,801 | 51,719 | 53,685 |
| Common Shares | 623 | 621 | 619 | 617 | 616 |
| Retained earnings | 615,805 | 553,480 | 470,225 | 392,114 | 319,798 |
| Other shareholders' equity | -16,865 | -14,955 | -9,447 | -10,910 | -9,538 |
| TOTAL | $1,150,704 | $1,083,981 | $1,060,831 | $1,009,599 | $1,024,649 |
| Total Liabilities And Equity | $1,697,355 | $1,626,595 | $1,647,492 | $1,556,401 | $1,561,435 |